연구성과로 돌아가기

2025 연구성과별 연구자 정보 (359 / 1187)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ⓘ ORCID ORCID Author Name Related Email
Effects on Physicochemical, Nutritional, and Quality Attributes of Fortified Vegan Muffins Incorporated with Hempseed as an Alternative Protein Source ⓘ Du, Huimin ⓘ Du, HM ⓘ 1 Kyungpook Natl Univ, Sch Food Sci & Technol, Daegu 41566, South Korea ⓘ AAA-3311-2019 ⓘ Niu, Bailin ⓘ ⓘ ⓘ duhuimin1998@naver.com; ggotari@naver.com; yunju@knu.ac.kr; nurulsaadah.said@gmail.com; wonyoung@knu.ac.kr; ⓘ
Effects on Physicochemical, Nutritional, and Quality Attributes of Fortified Vegan Muffins Incorporated with Hempseed as an Alternative Protein Source ⓘ Baek, Inha ⓘ Baek, I ⓘ 2 Kyungpook Natl Univ, Sch Food Sci & Technol, Daegu 41566, South Korea ⓘ ⓘ ⓘ ⓘ ⓘ duhuimin1998@naver.com; ggotari@naver.com; yunju@knu.ac.kr; nurulsaadah.said@gmail.com; wonyoung@knu.ac.kr; ⓘ
Effects on Physicochemical, Nutritional, and Quality Attributes of Fortified Vegan Muffins Incorporated with Hempseed as an Alternative Protein Source ⓘ Jang, Yunju ⓘ Jang, Y ⓘ 3 Kyungpook Natl Univ, Sch Food Sci & Technol, Daegu 41566, South Korea ⓘ ⓘ ⓘ ⓘ ⓘ duhuimin1998@naver.com; ggotari@naver.com; yunju@knu.ac.kr; nurulsaadah.said@gmail.com; wonyoung@knu.ac.kr; ⓘ
Effects on Physicochemical, Nutritional, and Quality Attributes of Fortified Vegan Muffins Incorporated with Hempseed as an Alternative Protein Source ⓘ Said, Nurul Saadah ⓘ Said, NS ⓘ 4 Kyungpook Natl Univ, Sch Food Sci & Technol, Daegu 41566, South Korea ⓘ LFV-3208-2024 ⓘ Said, Nurul Saadah ⓘ 0000-0002-8077-924X ⓘ Said, Nurul Saadah ⓘ duhuimin1998@naver.com; ggotari@naver.com; yunju@knu.ac.kr; nurulsaadah.said@gmail.com; wonyoung@knu.ac.kr; ⓘ
Effects on Physicochemical, Nutritional, and Quality Attributes of Fortified Vegan Muffins Incorporated with Hempseed as an Alternative Protein Source ⓘ Lee, Won Young ⓘ Lee, WY ⓘ 5 교신저자 Kyungpook Natl Univ, Sch Food Sci & Technol, Daegu 41566, South Korea ⓘ AAL-2780-2021 ⓘ Lee, Wonyoung ⓘ 0000-0001-5850-9692 ⓘ Lee, Wonyoung ⓘ duhuimin1998@naver.com; ggotari@naver.com; yunju@knu.ac.kr; nurulsaadah.said@gmail.com; wonyoung@knu.ac.kr; ⓘ
Effects on Physicochemical, Nutritional, and Quality Attributes of Fortified Vegan Muffins Incorporated with Hempseed as an Alternative Protein Source ⓘ Lee, Won Young ⓘ Lee, WY ⓘ 5 교신저자 Kyungpook Natl Univ, Res Inst Tailored Food Technol, Daegu 41566, South Korea ⓘ AAL-2780-2021 ⓘ Lee, Wonyoung ⓘ 0000-0001-5850-9692 ⓘ Lee, Wonyoung ⓘ duhuimin1998@naver.com; ggotari@naver.com; yunju@knu.ac.kr; nurulsaadah.said@gmail.com; wonyoung@knu.ac.kr; ⓘ
Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study ⓘ Jia, Jidong ⓘ Jia, JD ⓘ 1 Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China ⓘ ⓘ ⓘ ⓘ ⓘ jia_jd@ccmu.edu.cn; ⓘ
Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study ⓘ Lin, Bingliang ⓘ Lin, BL ⓘ 2 Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou, Peoples R China ⓘ ⓘ ⓘ ⓘ ⓘ jia_jd@ccmu.edu.cn; ⓘ
Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study ⓘ Hu, Peng ⓘ Hu, P ⓘ 3 Chongqing Med Univ, Affiliated Hosp 2, Affiliated Hosp 1, Chongqing, Peoples R China ⓘ ⓘ ⓘ ⓘ ⓘ jia_jd@ccmu.edu.cn; ⓘ
Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study ⓘ Xie, Qing ⓘ Xie, Q ⓘ 4 Shanghai Jiaotong Univ, Ruijin Hosp, Sch Med, Shanghai, Peoples R China ⓘ ⓘ ⓘ ⓘ ⓘ jia_jd@ccmu.edu.cn; ⓘ
Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study ⓘ Douglas, Mark ⓘ Douglas, M ⓘ 5 Univ Sydney, Westmead Inst Med Res, Sydney, Australia ⓘ ⓘ ⓘ ⓘ ⓘ jia_jd@ccmu.edu.cn; ⓘ
Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study ⓘ Douglas, Mark ⓘ Douglas, M ⓘ 5 Westmead Hosp, Sydney, Australia ⓘ ⓘ ⓘ ⓘ ⓘ jia_jd@ccmu.edu.cn; ⓘ
Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study ⓘ Lv, Fangfang ⓘ Lv, FF ⓘ 6 Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Hangzhou, Peoples R China ⓘ ⓘ ⓘ ⓘ ⓘ jia_jd@ccmu.edu.cn; ⓘ
Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study ⓘ Tak, Won Young ⓘ Tak, WY ⓘ 7 Kyungpook Natl Univ Hosp, Daegu, South Korea ⓘ ⓘ ⓘ ⓘ ⓘ jia_jd@ccmu.edu.cn; ⓘ
Efficacy and safety of elebsiran and pegylated interferon alfa combination therapy versus pegylated interferon alfa in participants with chronic hepatitis B virus infection: follow-up results from the ongoing phase 2, randomized, open-label ENSURE study ⓘ Cao, Ke ⓘ Cao, K ⓘ 8 Brii Biosci Beijing Co Ltd, Beijing, Peoples R China ⓘ ⓘ ⓘ ⓘ ⓘ jia_jd@ccmu.edu.cn; ⓘ
페이지 이동: